These cognitive deficits were associated with the upregulation of Aβ-positive-neurons, hyperphosphorylated Tau-positive neurons and NFTs in the hippocampal and mPFC areas, the regions responsible for cognition. The gene discussed is MAPT; the disease is Cognitive impairment.